19

Habtamu Bayih Engida, Meseret Adugna Mamuye , Yohannes Tekleab Yehun , Abel Girma Guadie , Yinager Agi- die Dagnew , Tesfaye Taye Gelaw , Gizachew Tadesse Wassie , Zelalem Alamrew Anteneh Ethiop Med J, 2022, Vol. 60 No. 1

PATTERNS OF CARDIOVASCULAR DISEASES AMONG CARDIAC DISEASE SUS-

PECTED PATIENTS IN BAHIR DAR CITY, ETHIOPIA

Habtamu Bayih Engida MD, Cardiologist1, Meseret Adugna Mamuye MD, Internist2, Yohannes Tekleab Yehun MD, Cardiologist1, Abel Girma Guadie MD, Internist2, Yinager Agidie Dagnew MD, Internist 2, Tesfaye Taye Gelaw MD, Cardiologist3, Gizachew Tadesse Wassie MPH4, Zelalem Alamrew Anteneh MSC*4

ABSTRACT

Background: Rheumatic heart disease (RHD) has remained a substantial public health challenge in low and mid- dle-income countries. We aimed to determine the prevalence and associated factors of RHD among patients who received echocardiographic examinations.

Methods: A total of 849 patients who underwent echocardiography examinations were included in the study. Descriptive statistics and logistic regression analysis were performed. The odds ratio with 95% confidence inter- val, and p-values were used to determine the presence of associations.

Results: A total of 849 cardiac disease suspected cases were included in the analysis, of which 406 (47.8%) had a definite cardiac disorder. RHD is responsible for 76(18.2%) of the total cardiovascular disorders. The preva- lence of RHD was 76(9.0%) among the total study population. The sex and age of the patients showed associa- tions with rheumatic heart disease. The odds of having RHD among females was nearly three times that of male counterparts (AOR= 2.9, 95%CI: 1.6-5.4). Besides, the odds of having RHD among younger than 24, and from 25 to 35 was seventeen times that of respondents older than 50 years of age (AOR=17.2, 95%CI: 7.2-41.5, & AOR= 17.1, 95%CI: 7.3-40.0) respectively.

Conclusions: One-half of the cardiac disease suspected individuals had a definite cardiac disease, and RHD ac- counted for 18.2% of the total cardiac diseases. Younger age and female in gender were associated with greater likelihood of having RHD. Therefore, interventions should be tailored to the magnitude of the problem; females and younger age groups should be the focus of concern.

Keywords: Cardiac disease, Rheumatic heart disease, Echocardiography, Ethiopia

INTRODUCTION

Cardiovascular diseases (CVDs) are a group of disor- ders of the heart and blood vessels. Rheumatic heart disease(RHD) is one of the CVDs that result in dam- age to the heart muscle and valves from rheumatic fever caused by streptococcal bacteria(1). Cardiovas- cular diseases (CVDs) are the leading cause of death globally; evidence shows that more people die annual- ly from CVDs than from any other cause. Nearly, 17.9 million people died from CVDs in 2016, representing 31% of all global deaths. Over three-quarters of CVD deaths take place in low- and middle-income countries (1, 2).

RHD remains an important public health challenge across the globe; it accounts for more than 15.6 mil- lion cases worldwide each year, however, low and middle-income countries are disproportionately affect- ed (3, 4). The disease persists in all countries of WHO regions, however, the African, South-East

Asia, and Western Pacific regions are the worst affected, accounting for 84% of all prevalent cases and 80% of all estimated deaths due to RHD(5).

According to health institution level studies con- ducted in Africa, RHD is the main cause of heart failure and is responsible for more than 34.0% of cardiovascular disease-related hospital admissions (6, 7). RHD mostly affects the population in low and middle-income countries, particularly; where poverty is widespread. RHD commonly affects chil- dren and can result in life-long disability or death. Effective early intervention can prevent premature mortality from RHD(4, 8).

A country like Ethiopia, whose economy is very weak, and the population living standard is very low, and more than 30% of the population living below the national poverty line bears the highest potential risk of communicable diseases including RHD (9). In addition, as RHD is more common in

1 Department of Internal Medicine Cardiac Unit, School of Medicine, Bahir Dar University, Bahir Dar, Ethiopia 2 Departments of Internal Medicine, School of Medicine, Bahir Dar University, Bahir Dar, Ethiopia 3Department of Pediatrics, School of Medicine, Bahir Dar University, Bahir Dar, Ethiopia

4 Departments of Epidemiology, School of Public Health, Bahir Dar University, Bahir Dar, Ethiopia Correspondent author email: Zelalem Alamrew Anteneh ([email protected])

young age, and Ethiopia is a country of young popula- tion with over 70 percent of the total population is below the age of 30, and about 45 percent of the popu- lation is below 15 years of age, as a consequence, the country pertains highest potential risk of RHD, and other cardiovascular diseases (10, 11). However, stud- ies conducted on cardiovascular disease including RHD are very scarce.

Therefore, this study aimed to determine the pattern of RHD among patients suspected of heart disease and who underwent echocardiography examinations. Fur- thermore, our study aims to produce hypotheses for future study directions and to have some insight into the contributing factors for RHD.

METHOD AND MATERIALS

Study design and setting: a cross-sectional study de- sign was used among patients visiting cardiac clinics from October 1, 2019 to October 1, 2020. The study was conducted in two hospitals (Felege Hiwot Refer- ral and Addinas General) hospitals. The hospitals are found in Bahir Dar City, located at 560 km distance from Addis Ababa, the capital city of Ethiopia. These hospitals are a few of the health institutions that pro- vide cardiovascular disease examinations and inter- ventions in the city. Patients suspected of a cardiac problem from different health institutions and nearby regions are commonly referred to these hospitals for diagnosis and intervention.

Echocardiographic examination was performed in the parasternal long axis, short axis, apical four chambers, and occasionally in the subcostal and suprasternal views using GE and Sonoscape echocardiography machines at Adinas & Felege Hiwot hospitals. Indices were analyzed and presented in the left ventricle sys- tolic diameter (LVIDS), left ventricle diastolic diame- ter (LVIDD), and the ejection fraction (EF). All the echocardiographic diagnoses were based the Ameri- can Society of Echocardiogram and World Heart Fed- eration guidelines (12, 13).

Study period: we included patients who received echocardiographic examinations from October 1, 2019, to October 1, 2020) and the data was collected from June 15, to May 10, 2021.

Sample size and sampling technique

All patients for whom echocardiography diagnostic tests were carried out in the two hospitals during the selected one-year period were included in this study. A total of 849 cardiac disease suspected patients were included in our final analysis. As eligibility criteria, our analysis considered only the first echocardio- graphic examination reports of each patient in the study.

Study variables

Both hospitals use cardiac disease examination tools consisting of age, the gender of the patients, and the echocardiographic diagnosis.

20

Rheumatic heart disease, is the outcome varia- ble of interest for this study, and age, and gender were independent factors available on the charts and used for this study.

Other cardiac disorders: ischemic heart disease, hypertensive heart disease, Pericardial Effusion, Dilated Cardiomyopathy (DCMP), Degenerative valvular heart diseases (DVHD), Cor-plumonale, pulmonary hypertension, etc

Operational definitions

RHD: According to the World Heart Federation (WHF) criteria for echocardiographic diagnosis of RHD as defined by the presence of any evidence of mitral or aortic regurgitation seen in two planes associated with at least two of the following mor- phologic abnormalities of the regurgitating valve: restricted leaflet motility, focal or generalized val- vular thickening, and abnormal sub-valvular thick- ening (13).

Ischemic heart disease: were documented by detec- tion of regional wall motion abnormality on a dif- ferent region of the heart (such as loss systolic thickening, hypokinesia, akinesia dyskinesia) and associated with LV systolic dysfunction(14).

Hypertensive heart disease: was diagnosed in the presence of any or combination of the following abnormalities: left ventricular diastolic dysfunction (e.g. altered E: A ratio), left ventricular hypertro- phy, left ventricular systolic dysfunction, and dilat- ed left atrium, a surrogate of impaired LV filling in the presence of hypertension(15).

Pericardial Effusion: This was diagnosed when there is echo-free space between the visceral and parietal pericardium(16).

Dilated Cardiomyopathy (DCMP),: was diagnosed when there are dilated heart chambers with normal or decreased wall chambers as well as impaired LV systolic function(17).

Cor-plumonale: was present when there is dilated and hypertrophied right ventricle (RV), evidence of increased RV systolic pressure D-shaped LV in diastole (diastolic flattening of the LV septum) (18).

Data management and analysis

The data received from the hospitals were entered into SPSS software version 26 for analysis. Data cleaning was performed to make it ready for analy- sis. Then after descriptive statistics such as fre- quency distributions, percentages for categorical variables, and median, and interquartile range for the continuous variable were performed. Logistic regression analysis between rheumatic heart dis- ease, and demographic factors (sex and age) were performed to see the crude effect of these factors on rheumatic heart disease. The results were pre- sented in tables, and figures for the descriptive study, and odds ratio with its 95% confidence level and p-values were used for the logistic regression analysis.

Ethical approval

Ethical clearance was obtained from the research and the ethical review committee of Bahir Dar University. Permissions were received from Felege Hiwot Refer- ral Hospital and Addinas General Hospital to use the echocardiography data from the cardiac unit. The data were anonymous; there are no names or any personal identifier in the data.

RESULTS

Demographic characteristics of patients visiting car- diac clinics in Bahir Dar city

This study analyzed a total of 849 patients suspected of having cardiac disorder for which echocardiog- raphy examinations were done. About 55% of the study participants were males, and 44% were younger than 49 years of age. The ages of the respondents were varied between 6 and 103 years, the median and inter- quartile range for the ages was 52, and 34.6 years re- spectively. This study was conducted in two hospitals, 490 (57.7%) of the cases were from Addinas hospital, and the remainings were from FelgeHiwot hospital

(table 1).

patients suspected of cardiac

 

 

 

 

 

Chi-square

20.6

85.6

 

0.2

Percent

44.4 55.6

13.3 16.1

14.7 55.8

57.7 42.3

frequency

 

 

 

 

Table 1: Demographic characteristics of disease in Bahir Dar city

377 472

113 137

125 474

490 359

Categories

Male Female

<24 25-35

36-49 >49

Addinas Felege Hiwot

Variable

Sex

Age in years

 

Hospital

 

 

 

 

 

Cardiac diseases distribution among patients under- went echocardiography examinations in Bahir Dar city

Out of 849 individuals with health problems that un- derwent echocardiography diagnosis 406 (47.2%) had a definite cardiac disease. The prevalence of RHD was 76 (9.0%); it accounts for 18.2% of the total cases of

21

revealed that the prevalence of hypertensive heart disease (HHD) was 80(9.4%), ischemic heart dis- ease (IHD) was 59(6.9%), degenerative valvular heart disease (DVHD) was 63(7.4%), and dilated cardiomyopathy (DCMP) was, 56(6.6%) (Table 2).

Table 2: Diagnostic classifications of cardiac patients using Transthoracic Echocardiography Examinations in Bahir Dar city

Cardiac diseases

Frequency

Percentage

 

 

 

Hypertensive Heart

 

 

Disease (HHD)

80

9.4

Yes

No

769

90.6

Rheumatic Heart

 

 

Disease (RHD)

76

9

Yes

NO

773

91

Degenerative Valvu-

 

 

lar Heart diseases

63

7.4

(DVHD)

Yes

786

92.6

No

 

 

Ischemic Heart Dis-

 

 

ease (IHD)

59

6.9

Yes

No

790

93.1

Dilated Cardiomyo-

 

 

pathy (DCMP)

56

6.6

Yes

No

793

93.4

Pericardial Effusion

 

 

(PE)

43

5.1

Yes

No

806

94.9

Co-pulumonale

36

4.2

Yes

No

813

95.8

Restrictive cardio-

 

 

myopathy (RCM)

14

98.4

Yes

No

835

1.6

Congenital heart

 

 

disease (CHD)

6

0.7

Yes

No

843

99.3

Overall Cardiac

 

 

disease

406

47.8

Yes

No

443

52.2

22

Echocardiographic diagnostic classifications by gender among cardiac patients in Bahir Dar city

Gender distributions of cardiac diseases indicated that rheumatic heart disease was much higher among females compared to males of the total confirmed cardiac cases (61 vs. 15) p-value (<0.001), ischemic heart disease is higher for males than females (36, vs. 23) p-value (<0.008), and similarly dilated cardiomyopathy was higher for males compared to females (33 vs. 23) p-value (0.02) (table 3).

Table 3: Echocardiographic diagnostic classifications by gender in cardiac patients in Bahir Dar City

Disease

Male, n

Female, n

Total (%)

Chi square

P-value

HHD

42

38

80(19.7)

2.3

0.12

RHD

15

61

76(18.7)

20.6

<0.001

DVHD

30

33

63(15.5)

0.7

0.4

IHD

36

23

59(14.5)

7.1

0.008

DCMP

33

23

56(13.8)

5.1

0.02

PE

22

21

43(10.6)

0.84

0.36

Co-pulumonale

13

23

36(8.9)

1.1

0.31

RCM

6

8

14(3.5)

0.01

0.9

CHD

1

5

6(1.5)

1.9

0.2

Any cardiac disease

183

223

406(47.8%)

0.5

0.7

Valvular lesions among RHD patients in Bahir Dar city

Our study showed that 58 (7.5%) and 199 (23.4%) of the study participants had mitral stenosis and regurgitations respectively. In addition, 29(3.4%) and 104(12.2%) of the study participants had aortic stenosis and regurgitations respectively. About 56(96.6%) of the total patients with mitral stenosis and 54(27.1%) of mitral regurgitations were positive for RHD. Besides, one out of four patients with aortic stenosis and one in three patients with aortic regurgitations were positive for RHD.

The findings of this study also indicated that some cardiac patients reported having more than one valvular lesion. More specifically, the distribution of RHD among cardiac patients with more than one lesion varies based on the kind of valvular lesion combined; 38(86.4%) cases with MS and MR, 7(35%) with AS and AR were positive for RHD (Table 4).

Table 5: The frequency distributions & percentages of Valvular lesions based on severity among patients

who underwent echocardiographic examinations in Bahir Dar city

Valvular lesions

 

Severity

 

RHD (N=76)

 

Mild

Moderate

Severe

 

Mitral stenosis (n=58)

17(26.6%)

11(17.2%)

30(56.3%)

58(76.3%)

Mitral regurgitation (n=199)

123(61.8%)

53(26.6%)

23(11.6%)

54(71.7%)

Aortic stenosis (n=29)

15(51.7%)

10(34.5%)

4(13.7%)

8(10.5%)

Aortic regurgitation (n=104)

79(75.2%)

21(20%)

4(3.8%)

34(44.7%)

Regression analysis of rheumatic heart disease by sex and age among patients underwent echocardi- ography examinations

This study is based on echocardiographic diagnostic tests in patients suspected of cardiac disease. Our data contain only sex and age as potential confound- ing factors that entered both in bivariate and multi- variate regression analysis. Both the sex and age of the patients showed associations with RHD. The study revealed that females were more likely to be positive for RHD, where the odds of having a posi- tive diagnosis for RHD among females was nearly three times that for male patients (AOR= 2.9, 95%CI: 1.6-5.4). Similarly,

23

the age of the respondents was showed strong as- sociations with RHD; the odds of disease were significantly higher among the young age group than older ones. The odds of RHD among respond- ents whose age was 35 years or younger was sev- enteen times that of respondents older than 50 years of age (table 6).

Table 6: Regression analysis of rheumatic heart disease for sex and age among patients who under- went echocardiography examinations in Bahir Dar city

Variable

 

Classifications

RHD

 

OR (95% CI for OR)

 

P-value

 

 

 

Yes

No

Crude

Adjusted

 

Sex

 

Male

15

362

1.00

1.00

0.001

 

 

Female

61

411

3.58(2.01-6.41

2.9(1.6-5.4)

 

 

 

 

 

 

 

 

Age

in

<24

24

89

18(7.5-43.0)

17.2(7.2-41.5)

<0.001

years

 

25-35

31

106

19.5(8.4-45.5)

17.1(7.3-40.0)

 

 

36-49

14

111

8.4(3.3-21.3)

7.5(3.0-19.2)

 

 

 

>49

7

467

1.00

1.00

 

 

 

 

 

 

 

 

 

Discussions

Current evidence shows that CVDs are the leading causes of death globally. Low and middle-income countries are disproportionately affected by the dis- ease, where over 80% of these deaths take place (2, 19). However, there is a limited number of studies available to show the burden, distribution, and deter- minant factors for CVDs including RHD in low- income countries. Therefore, this study was aimed to determine the prevalence and the associated factors of RHD among cardiac disease suspected patients.

Accordingly, 406 (47.8%) of patients who underwent echocardiographic examinations reported having a definite cardiac disease. Our finding is supported by a study conducted in Buea, South West Region of Cameroon, where 45.2% of patients who had under- gone echocardiographic tests had a definite CVS (20). In the current study, nearly one in ten patients (9.0%) of the study participants that received echo- cardiographic tests were positive for RHD. This find- ing is in accordance with a study conducted by Nige- rian savannah, where 9.8% of the study subjects with abnormal results had an echocardiographic diagnosis of RHD (21). However, the magnitude of RHD in the current study is much higher than other studies, where the proportion of RHD lies in the ranges of 3.1% to 6.5% (20, 22, 23). The difference may be attributed to several reasons such as

variations in socioeconomic status, gender ratio, and age composition in the study population. In addition, our study domain was patients suspected of cardiac disease and who visited cardiac treat- ment centers seeking interventions; this might in- crease the magnitude of RHD in our study popula- tion unlike similar studies conducted among appar- ently healthy individuals.

In this study, of the cardiac patients with mitral stenosis, 56(96.6%) were positive for RHD. This is supported by the evidence that most mitral stenosis cases among cardiac patients are caused by RHD (24). Likewise, studies conducted so far revealed that in most of the cases, cardiac patients with mi- tral stenosis were positive for RHD (25, 26). Our findings also showed that nearly, 30% of patients who reported having mitral regurgitations were positive for RHD. This finding is in line with simi- lar other study findings where the RHD manifests as congestive heart failure due to valvular involve- ment including mitral valve regurgitations (27, 28). In this study, the prevalence of RHD was signifi- cantly higher among females compared to males, 61(80%) vs. 15(20%) respectively. Furthermore, the odds of having RHD among the female was about three times more likely as compared to their male counterparts in patients suspected of cardiac diseases. This finding is supported by several

pieces of evidence, where the female sex is at higher risk of acquiring RHD compared to males. A review study conducted on the impacts of gender on RHD, all review articles included were showed that a female predominance for RHD (29).

Similarly, a study conducted in India showed that the prevalence of RHD was more than two-fold higher in females than males (71.4% vs. 29.6%) (30). Besides, several studies across the globe indicated that the risk of RHD varies for women and men (31-33).

The age of the respondents showed a strong associa- tion with RHD; the disease was significantly higher among the young age group than older ones. The odds of RHD among respondents younger than 35 years of age was more than seventeen times that of older than 50 years of age. Evidence showed that virtually any- one at any age can get RHD; however, the risk is highest among children and young adults (34-36). Our finding is supported by the evidence from other stud- ies that RHD is more prevalent among young age than older ones; a study conducted in Fiji Oceania among participants between the ages of 5 to 65 years, almost half of RHD cases occurred before age 40 years (37). Similarly, several studies conducted across the globe indicated that the risks of RHD inversely correlated with age, showing that as the age of study participants increases the risk of RHD decreases (8, 36, 38).

This study was conducted merely based on echocardi- ographic examinations done for cardiac disease sus- pected patients. The data was primarily collected for the purpose of diagnosis and intervention. Our study has drawbacks in terms of controlling confounding factors for RHD, because the data composed of only sex and age as confounding factors; the remaining data is all about clinical information such as sign, symptom, specific diagnosis of cardiac diseases, and intervention plan.

24

Conclusion

In this study, one in ten cardiac suspected cases were positive for RHD. Males and females with the cardiac disorder have different risk profiles for rheumatic heart disease that might have a substan- tial impact on the prognosis and treatment out- comes. The odds of RHD among the females is three times that of males. In addition, the odds of RHD inversely decreases with age, the young age groups were at a higher risk of getting the disease compared to older ones. In general, RHD is sub- stantially higher in this study compared to several studies available, indicating that it is an important public health challenge to our community. There- fore, interventions should be tailor the magnitude of the problem, and should also target females and young age groups.

Competing interests

The authors declare that they have no competing interests.

Authors’ contribution

HB and ZAA- conceptualized the study, designed the study, performed data analysis, interpreted the findings, and drafted the manuscript.

MA, YK, AG, YA…and GTW - critically re- viewed the report and manuscript.

All authors read and approved the final version of the manuscript.

ACKNOWLEDGMENT

We received the data from the Felege Hiwot Refer- ral Hospital and Addinas General Hospital. We like to thank the Felege Hiwot Referral Hospital and Addinas Hospital administration offices for grating us the data.

REFERENCES

1.Hopkins J. Rheumatic Heart Disease 2021 [cited 2021 11 Nov. 2021]. Available from: https:// www.hopkinsmedicine.org/health/conditions-and-diseases/rheumatic-heart-disease.

2.World Health Organization. Cardiovascular diseases (CVDs) 2017 [cited October 20,2020]. Available from: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).

3.Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. The Lancet Infectious diseases. 2005;5(11):685-94. Epub 2005/10/29. doi: 10.1016/s1473-3099(05)70267-x. Pub- Med PMID: 16253886.

4.S.R.A Dodu SB. Rheumatic heart fever and rheumatic heart disease in developing countries. World Health Forum. 1989.

5.Rheumatic fever and rheumatic heart disease [Internet]. WHO. 2018 [cited 15 October, 2020]. Available from: https://apps.who.int/gb/ebwha/pdf_files/WHA71/A71_25-en.pdf?ua=1.

6.Liesl Zühlke MM, Eloi Marijon. Congenital heart disease and rheumatic heart disease in Africa: recent ad- vances and current priorities. BMJ. 2013;99(21).

7.Nkoke C JA, Makoge C, Teuwafeu D, Nkouonlack C, Dzudie A. Epidemiology of cardiovascular diseases related admissions in a referral hospital in the South West region of Cameroon: A cross-sectional study in sub- Saharan Africa. PLoS ONE 2019;14(12).

25

8.AO M. Rheumatic heart disease in Africa: is there a role for genetic studies? Cardiovasc J Afr. 2015;26(2 Suppl 1):S21-6.

9. The World Bank. Ethiopia Poverty Assessment [cited 2020 10 october]. Available from: https:// www.worldbank.org/en/topic/poverty/publication/ethiopia-poverty-assessment.

10.Reviews WEn. EDUCATION SYSTEM PROFILES 2018 [cited 2020 12 October]. Available from: https:// wenr.wes.org/2018/11/education-in-ethiopia.

11.Assefa Admassie SN, Shelley Megquier. Harnessing the Demographic Dividend in Ethiopia 2017 [cited 2020 5 December]. Available from: https://www.prb.org/harnessing-the-demographic-dividend-in-ethiopia/.

12.Mitchell C, Rahko PS, Blauwet LA, Canaday B, Finstuen JA, Foster MC, et al. Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: Recommendations from the Ameri- can Society of Echocardiography. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. 2019;32(1):1-64. Epub 2018/10/05. doi: 10.1016/ j.echo.2018.06.004. PubMed PMID: 30282592.

13.Reményi B, Nigel Steer, Andrew Ferreira, et al. World Heart Federation criteria for echocardiographic diagno- sis of rheumatic heart disease--an evidence-based guideline. Nat Rev Cardiol. 2012;9(5):297-309. doi: 10.1038/nrcardio.2012.7. PubMed PMID: 22371105.

14.Paelinck BP. Ischemic Heart Disease, Ultrasound. In: Baert AL, editor. Encyclopedia of Diagnostic Imaging.

Berlin, Heidelberg: Springer Berlin Heidelberg; 2008. p. 1026-8.

15.Janardhanan RK, Christopher M. Imaging in hypertensive heart disease. Expert Rev Cardiovasc Ther. 2011;9 (2):199-209. doi: 10.1586/erc.10.190. PubMed PMID: 21453216.

16.Bernhard Maisch PMS, Arsen D. Ristic et al. Guidelines on the Diagnosis and Management of Pericardial Diseases. The European Society of Cardiology. 2004:1-28. doi: doi:10.1016/j.ehj.2004.02.001.

17.Thomas Mathew LW, Govardhan Navaratnam et al Diagnosis and assessment of dilated cardiomyopathy: a guideline protocol from the British Society of Echocardiography. Birtish Society of Cardiography. 2017;4 (2):G1–G13.

18.Mandoli GE, Sciaccaluga C, Bandera F, Cameli P, Esposito R, D’Andrea A, et al. Cor pulmonale: the role of traditional and advanced echocardiography in the acute and chronic settings. Heart Failure Reviews. 2020. doi: 10.1007/s10741-020-10014-4.

19.Gaziano TAB, Asaf Anand, Shuchi Abrahams-Gessel, Shafika. Growing epidemic of coronary heart disease in low- and middle-income countries. Curr Probl Cardiol. 2010;35(2):72-115. doi: 10.1016/ j.cpcardiol.2009.10.002. PubMed PMID: 20109979.

20.Nkoke CM, C. Dzudie, A. Mfeukeu, L. K. Luchuo, E. B. Menanga, A. Kingue, S. A predominance of hyper- tensive heart disease among patients with cardiac disease in Buea, a semi-urban setting, South West Region of Cameroon. BMC Res Notes. 2017;10(1):684. Epub 2017/12/06. doi: 10.1186/s13104-017-3034-6. PubMed PMID: 29202813; PubMed Central PMCID: PMCPMC5715493.

21.Sani MUK, K. M. Borodo, M. M. Prevalence and pattern of rheumatic heart disease in the Nigerian savannah: an echocardiographic study. Cardiovasc J Afr. 2007;18(5):295-9. Epub 2007/10/25. PubMed PMID: 17957324; PubMed Central PMCID: PMCPMC3975544.

22.Gemechu TM, H. Parry, E. H. Phillips, D. I., acoub MH. Community-based prevalence study of rheumatic heart disease in rural Ethiopia. Eur J Prev Cardiol. 2017;24(7):717-23. Epub 2017/01/11. doi: 10.1177/2047487316687104. PubMed PMID: 28071960.

23.Nkoke CD, A. Makoge, C. Luchuo, E. B. Jingi, A. M. Kingue, S. Rheumatic heart disease in the South West region of Cameroon: a hospital based echocardiographic study. BMC Res Notes. 2018;11(1):221. Epub 2018/04/05. doi: 10.1186/s13104-018-3341-6. PubMed PMID: 29615091; PubMed Central PMCID: PMCPMC5883525.

24.Korzan SJ, Evan Mutneja, Rahul Grover, Prashant. Mitral stenosis due to rheumatic heart disease - A rare cause of massive hemoptysis. Respir Med Case Rep. 2018;24:35-9. doi: 10.1016/j.rmcr.2018.03.007. PubMed PMID: 29977754.

25.Leal MTBC, Passos LSA, Guarçoni FV, Aguiar JMdS, Silva RBRd, Paula TMNd, et al. Rheumatic heart dis- ease in the modern era: recent developments and current challenges %J Revista da Sociedade Brasileira de Medicina Tropical. 2019;52.

26.Sticchi A. Mitral valve stenosis: epidemiology and causes in elderly patients. European Society of Cardiology. 2018;16(17).

27.Healio learn the heart. Rheumatic heart disease 2020 [cited 2020 29 December]. Available from: https:// www.healio.com/cardiology/learn-the-heart/cardiology-review/topic-reviews/rheumatic-heart-disease#.

28.Lembo NJ, Dell'Italia LJ, Crawford MH, Miller JF, Richards KL, O'Rourke RA. Mitral valve prolapse in pa- tients with prior rheumatic fever. Circulation. 1988;77(4):830-6. Epub 1988/04/01. doi: 10.1161/01.cir.77.4.830. PubMed PMID: 3349583.

29.Reuben K Mutagaywa A-MW, Apolinary Kamuhabwa et al. Rheumatic heart disease anno 2020: Impacts of gender and migration on epidemiology and management. Eur J Clin Invest. 2020;50(12).

26

30.Prakash Chand Negi AK, Sanjeev Asotra et al. Gender differences in the epidemiology of Rheumatic Fever/ Rheumatic heart disease (RF/RHD) patient population of hill state of northern India; 9 years prospective hos- pital based, HP-RHD registry. Indian Heart Journal. 2020;72(6):552-6. doi: https://doi.org/10.1016/ j.ihj.2020.09.011.

31.Ibrahim-Khalil S, Elhag M, Ali E, Mahgoub F, Hakiem S, Omer N, et al. An epidemiological survey of rheu- matic fever and rheumatic heart disease in Sahafa Town, Sudan. Journal of epidemiology and community health. 1992;46(5):477-9. Epub 1992/10/01. doi: 10.1136/jech.46.5.477. PubMed PMID: 1479314; PubMed Central PMCID: PMCPMC1059635.

32.Manuel Martínez-Sellés MAG-F, MarMoreno, et al Influence of Gender on the Etiology of Mitral Regurgita- tion. Revista Española de Cardiología 2006;59(12):1335-8.

33.Nitsche C, Koschutnik M, Kammerlander A, Hengstenberg C, Mascherbauer J. Gender-specific differences in valvular heart disease. Wiener klinische Wochenschrift. 2020;132(3):61-8. doi: 10.1007/s00508-019-01603-x.

34.Centers for disease control and prevention. Rheumatic Fever: All You Need to Know 2020 [updated 2018;

cited 2020 24 December]. Available from: https://www.cdc.gov/groupastrep/diseases-public/rheumatic- fever.html.

35.World Health Organization. Rheumatic Heart Disease 2020 [cited 2020 10 October].

36.World Heart federation. Rheumatic Heart Disease Geneva Switzerland2020 [cited 2020 24 December]. Avail- able from: https://www.world-heart-federation.org/global-advocacy/rheumatic-heart-disease/.

37.Parks T, Kado J, Miller AE, Ward B, Heenan R, Colquhoun SM, et al. Rheumatic Heart Disease-Attributable Mortality at Ages 5-69 Years in Fiji: A Five-Year, National, Population-Based Record-Linkage Cohort Study. PLoS Negl Trop Dis. 2015;9(9):e0004033-e. doi: 10.1371/journal.pntd.0004033. PubMed PMID: 26371755.

38.Paar JA, Berrios NM, Rose JD, Cáceres M, Peña R, Pérez W, et al. Prevalence of rheumatic heart disease in children and young adults in Nicaragua. Am J Cardiol. 2010;105(12):1809-14. Epub 2010/04/27. doi: 10.1016/j.amjcard.2010.01.364. PubMed PMID: 20538135.